Patent intelligence · Companies
Company patent strength
Data as of 13 Oct 2026Methodology
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead - toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. A filer's full profile - inventors, filing trend and quality index - comes with Technical Insights. See plans. See how we rank.
Why this page exists - and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space - open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
1,051 domestic filers with 5+ patents · page 8 · the top 500 are listed
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 351 | MYELIN FOUNDRY | 13 | 646.2% | 1 | 6 | 2019 - 2025 |
| 352 | OLEA BIO SCIENCE | 13 | 215.4% | 1 | 10 | 2024 - 2025 |
| 353 | PANDORUM TECHNOLOGIES | 13 | 17.7% | 1 | 11 | 2016 - 2026 |
| 354 | PRIMERAIL INFRALABS | 13 | 215.4% | 2 | 9 | 2017 - 2026 |
| 355 | RAYCHEM RPG | 13 | 1184.6% | 0 | 2 | 2016 - 2024 |
| 356 | REDSON RETAIL AND REALITY | 13 | 861.5% | 1 | 4 | 2021 - 2024 |
| 357 | SANSKRITECH SMART SOLUTIONS | 13 | 00% | 8 | 5 | 2019 - 2022 |
| 358 | SHIVALIK RASAYAN | 13 | 430.8% | 0 | 9 | 2020 - 2024 |
| 359 | SOUPHERB NUTRITION | 13 | 00% | 0 | 13 | 2023 - 2024 |
| 360 | STAR INDIA | 13 | 323.1% | 0 | 10 | 2018 - 2024 |
| 361 | TECHNOLOGY INNOVATION IN EXPLORATION MINING FOUNDATION | 13 | 00% | 0 | 13 | 2023 - 2026 |
| 362 | TESSERACT IMAGING | 13 | 00% | 0 | 13 | 2021 - 2024 |
| 363 | TOR AI | 13 | 538.5% | 1 | 7 | 2019 - 2024 |
| 364 | TRISPACE TECHNOLOGIES OPC | 13 | 969.2% | 2 | 2 | 2018 - 2025 |
| 365 | TVASTA MANUFACTURING SOLUTIONS | 13 | 646.2% | 2 | 5 | 2018 - 2024 |
| 366 | UNICHEM LABORATORIES | 13 | 430.8% | 0 | 9 | 2015 - 2025 |
| 367 | VOLTAS | 13 | 00% | 0 | 13 | 2022 - 2024 |
| 368 | AARTI PHARMALABS | 12 | 758.3% | 0 | 5 | 2018 - 2024 |
| 369 | BABALU KISAN YANTRA | 12 | 00% | 0 | 12 | 2024 - 2025 |
| 370 | BDR PHARMACEUTICALS INTERNATIONAL | 12 | 325% | 0 | 9 | 2018 - 2024 |
| 371 | BGAUSS AUTO | 12 | 433.3% | 8 | 0 | 2024 - 2025 |
| 372 | BIOTECH VISION CARE | 12 | 18.3% | 0 | 11 | 2020 - 2024 |
| 373 | CALICHE | 12 | 433.3% | 1 | 7 | 2021 - 2025 |
| 374 | CG POWER AND INDUSTRIAL SOLUTIONS | 12 | 18.3% | 6 | 5 | 2017 - 2024 |
| 375 | CLOUDPHYSICIAN HEALTHCARE | 12 | 866.7% | 1 | 3 | 2020 - 2025 |
| 376 | DROAME | 12 | 325% | 0 | 9 | 2023 - 2025 |
| 377 | EMAESTRO TECHNOLOGIES | 12 | 216.7% | 0 | 10 | 2024 - 2026 |
| 378 | FORENSIXAI TECHNOLOGIES | 12 | 00% | 0 | 12 | 2026 - 2026 |
| 379 | FUJIFILM SERICOL INDIA | 12 | 758.3% | 0 | 5 | 2016 - 2025 |
| 380 | GARDEN REACH SHIPBUILDERS AND ENGINEERS | 12 | 1083.3% | 0 | 2 | 2016 - 2025 |
| 381 | GLS SPECIALITY CHEMICALS | 12 | 00% | 0 | 12 | 2025 - 2026 |
| 382 | HELLA INDIA AUTOMOTIVE | 12 | 325% | 0 | 9 | 2014 - 2025 |
| 383 | INDOFIL INDUSTRIES | 12 | 433.3% | 0 | 8 | 2016 - 2024 |
| 384 | IPL BIOLOGICALS | 12 | 758.3% | 0 | 5 | 2015 - 2023 |
| 385 | JSW STEEL COATED PRODUCTS | 12 | 433.3% | 0 | 8 | 2019 - 2025 |
| 386 | LUMINOUS POWER TECHNOLOGIES | 12 | 433.3% | 0 | 8 | 2019 - 2024 |
| 387 | MAHARASHTRA KNOWLEDGE | 12 | 433.3% | 1 | 7 | 2024 - 2026 |
| 388 | METALMAN AUTO | 12 | 541.7% | 0 | 7 | 2021 - 2025 |
| 389 | NATIONAL ENGINEERING INDUSTRIES | 12 | 433.3% | 0 | 8 | 2018 - 2024 |
| 390 | NERVANIK AI LABS | 12 | 650% | 0 | 6 | 2021 - 2025 |
| 391 | NT LABS | 12 | 325% | 0 | 9 | 2019 - 2024 |
| 392 | OBEN ELECTRIC VEHICLES | 12 | 12100% | 0 | 0 | 2021 - 2023 |
| 393 | ORDNANCE FACTORY MURADNAGAR A UNIT OF YANTRA INDIA | 12 | 00% | 0 | 12 | 2022 - 2026 |
| 394 | RENATUS WELLNESS | 12 | 00% | 1 | 11 | 2020 - 2025 |
| 395 | SAMTEL AVIONICS | 12 | 00% | 0 | 12 | 2025 - 2026 |
| 396 | SIMULANIS SOLUTIONS | 12 | 18.3% | 0 | 11 | 2024 - 2026 |
| 397 | SRI KANCHI KAMAKOTI MEDICAL TRUST | 12 | 433.3% | 0 | 8 | 2019 - 2024 |
| 398 | SUN PHARMA ADVANCED RESEARCH | 12 | 325% | 3 | 6 | 2017 - 2025 |
| 399 | SUVEN LIFE SCIENCES | 12 | 433.3% | 0 | 8 | 2016 - 2024 |
| 400 | SYMPHONY | 12 | 866.7% | 0 | 4 | 2015 - 2025 |
Educational institutes are excluded - see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy - directional, not advice; see methodology. Read the ranking methodology →
Patent coverage: 4,84,093 applications, 84.4% filed 2022 onward, 96% carry AI-generated technology tags. Earlier records, back to 2004, are largely granted cases, so pre-2022 years show survivors rather than full filing volume.